CSL (CSL) Share Price & Analysis


CSL Stock Chart & Stats

Day’s RangeAU$0 - AU$0
52-Week RangeAU$251.41 - AU$312.57
Previous CloseAU$310.29
Average Volume (3M)676.71K
Market Cap
Enterprise ValueAU$148.49B
Total Cash (Recent Filing)$10.44B
Total Debt (Recent Filing)$9.66B
Price to Earnings (P/E)47.7
Aug 16, 2023
1.12 (0.37%)
Share Statistics
EPS (TTM)6.51
Shares Outstanding482,369,261
10 Day Avg. Volume827,868
30 Day Avg. Volume676,714
Standard Deviation0.06
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit26.22
Enterprise Value/EbitdaN/A
Price Target Upside12.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6




What was CSL’s price range in the past 12 months?
CSL lowest share price was AU$251.41 and its highest was AU$312.57 in the past 12 months.
    What is CSL’s market cap?
    Currently, no data Available
    When is CSL’s upcoming earnings report date?
    CSL’s upcoming earnings report date is Aug 16, 2023 which is in 74 days.
      How were CSL’s earnings last quarter?
      CSL released its earnings results on Feb 13, 2023. The company reported AU$5.716 earnings per share for the quarter, beating the consensus estimate of AU$5.299 by AU$0.417.
        Is CSL overvalued?
        According to Wall Street analysts CSL’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does CSL pay dividends?
          CSL pays a Semiannually dividend of AU$1.53 which represents an annual dividend yield of 1.18%. See more information on CSL dividends here
            What is CSL’s EPS estimate?
            CSL’s EPS estimate is AU$2.6.
              How many shares outstanding does CSL have?
              CSL has 482,369,260 shares outstanding.
                What happened to CSL’s price movement after its last earnings report?
                CSL reported an EPS of AU$5.716 in its last earnings report, beating expectations of AU$5.299. Following the earnings report the stock price went up 0.898%.
                  Which hedge fund is a major shareholder of CSL?
                  Currently, no hedge funds are holding shares in AU:CSL


                  CSL Stock Smart Score

                  The CSL Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description


                  CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the CSL Behring and Seqirus segments. The CSL Behring segment provides plasma therapies and conducts early stage research on plasma and non plasma therapies. The Seqirus segment involves in the production of non-plasma biotherapeutic products and develops influenza related products. The company was founded on November 2, 1961 and is headquartered in Parkville, Australia.


                  Top 5 ETFs holding CSL

                  Market Value
                  Smart Score
                  iShares MSCI Australia ETF
                  iShares Global Healthcare ETF
                  UBS (Irl) ETF Plc - MSCI Australia UCITS ETF
                  UBS (Irl) ETF Plc - MSCI Australia UCITS ETF (hedged to GBP) A-acc
                  UBS (Irl) ETF plc - MSCI Australia UCITS ETF
                  Up to five ETFs with an Outperform Smart Score that hold CSL. The ETFs are listed according to market value of CSL within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Becton Dickinson
                  Thermo Fisher
                  Abbott Labs

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis